Stock Analysts’ updated eps estimates for Friday, September 18th:
Adicet Bio (NASDAQ:ACET) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $27.00 price target on the stock.
Autodesk (NASDAQ:ADSK) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $300.00 price target on the stock.
Amer Sports (NYSE:AS) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $42.00 price target on the stock.
Axsome Therapeutics (NASDAQ:AXSM) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $258.00 target price on the stock.
Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its neutral rating reaffirmed by analysts at Piper Sandler. The firm currently has a $50.00 target price on the stock, down from their previous target price of $53.00.
BCB Bancorp, Inc. (NJ) (NASDAQ:BCBP) was downgraded by analysts at Brean Capital from a buy rating to a neutral rating. They currently have $9.00 target price on the stock.
Bridgepoint Group (LON:BPT) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 360 target price on the stock.
Dutch Bros (NYSE:BROS) had its buy rating reaffirmed by analysts at TD Cowen. The firm currently has a $59.00 target price on the stock.
Cleveland-Cliffs (NYSE:CLF) had its buy rating reissued by analysts at Glj Research. The firm currently has a $15.60 target price on the stock.
Corcept Therapeutics (NASDAQ:CORT) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $165.00 price target on the stock.
Salesforce (NYSE:CRM) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $289.00 target price on the stock.
Salesforce (NYSE:CRM) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $315.00 price target on the stock.
CoreWeave (NASDAQ:CRWV) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $250.00 target price on the stock.
Cognizant Technology Solutions (NASDAQ:CTSH) had its hold rating reaffirmed by analysts at TD Cowen. The firm currently has a $54.00 price target on the stock.
Corteva (NYSE:CTVA) had its buy rating reaffirmed by analysts at Argus. The firm currently has a $91.00 target price on the stock.
Crane NXT (NYSE:CXT) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $85.00 target price on the stock.
CoreCivic (NYSE:CXW) had its buy rating reiterated by analysts at JonesTrading. They currently have a $42.00 target price on the stock.
CryoPort (NASDAQ:CYRX) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $25.00 price target on the stock.
DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $35.00 target price on the stock.
Dunelm Group (LON:DNLM) had its buy rating reissued by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 1,000 target price on the stock.
DexCom (NASDAQ:DXCM) had its buy rating reissued by analysts at TD Cowen. TD Cowen currently has a $95.00 target price on the stock.
Brinker International (NYSE:EAT) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $270.00 target price on the stock.
Brinker International (NYSE:EAT) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $300.00 target price on the stock.
Entain (LON:ENT) had its buy rating reiterated by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 988 price target on the stock.
EVI Industries (NYSEAMERICAN:EVI) had its buy rating reissued by analysts at DA Davidson. DA Davidson currently has a $32.00 target price on the stock.
Franklin BSP Realty Trust (NYSE:FBRT) was downgraded by analysts at BTIG Research from a buy rating to a neutral rating.
fuboTV (NYSE:FUBO) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $19.00 target price on the stock.
HCA Healthcare (NYSE:HCA) had its outperform rating reiterated by analysts at Leerink Partners. The firm currently has a $492.00 target price on the stock.
HubSpot (NYSE:HUBS) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $300.00 target price on the stock.
HubSpot (NYSE:HUBS) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $300.00 price target on the stock.
HubSpot (NYSE:HUBS) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $200.00 target price on the stock.
HubSpot (NYSE:HUBS) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $250.00 price target on the stock.
Innodata (NASDAQ:INOD) had its top pick rating reiterated by analysts at BWS Financial. The firm currently has a $140.00 target price on the stock.
Intuit (NASDAQ:INTU) had its hold rating reiterated by analysts at TD Cowen. They currently have a $346.00 price target on the stock.
Intuit (NASDAQ:INTU) had its outperform rating reaffirmed by analysts at Mizuho. The firm currently has a $430.00 target price on the stock.
Intuit (NASDAQ:INTU) had its hold rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $300.00 target price on the stock.
Intuit (NASDAQ:INTU) had its hold rating reissued by analysts at Truist Financial Corporation. The firm currently has a $300.00 target price on the stock.
Intuit (NASDAQ:INTU) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $385.00 target price on the stock.
Kohl’s (NYSE:KSS) had its neutral rating reissued by analysts at BTIG Research.
Magna International (NYSE:MGA) (TSE:MG) had its market perform rating reissued by analysts at BMO Capital Markets. The firm currently has a $70.00 price target on the stock, down from their previous price target of $76.00.
Morgan Advanced Materials (LON:MGAM) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 250 target price on the stock.
Micron Technology (NASDAQ:MU) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $1,500.00 price target on the stock.
NIQ Global Intelligence (NYSE:NIQ) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $21.00 price target on the stock.
Nutrien (NYSE:NTR) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $85.00 target price on the stock.
Nucor (NYSE:NUE) had its hold rating reissued by analysts at Freedom Broker. Freedom Broker currently has a $285.00 target price on the stock, down from their previous target price of $305.00.
Envista (NYSE:NVST) had its neutral rating reiterated by analysts at Piper Sandler. They currently have a $28.00 target price on the stock.
Envista (NYSE:NVST) had its hold rating reissued by analysts at Needham & Company LLC.
NEXT (LON:NXT) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a £187 price target on the stock.
ON (NYSE:ONON) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $37.00 price target on the stock.
Progressive (NYSE:PGR) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $250.00 price target on the stock.
Rentokil Initial (LON:RTO) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 480 target price on the stock.
Savannah Resources (LON:SAV) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 12 target price on the stock.
Surgery Partners (NASDAQ:SGRY) had its buy rating reissued by analysts at TD Cowen. They currently have a $19.00 target price on the stock.
Tenet Healthcare (NYSE:THC) had its outperform rating reiterated by analysts at Leerink Partners. The firm currently has a $309.00 price target on the stock.
Twist Bioscience (NASDAQ:TWST) had its sell rating reissued by analysts at BWS Financial. The firm currently has a $45.00 price target on the stock.
Upexi (NASDAQ:UPXI) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $2.00 price target on the stock.
Vistry Group (LON:VTY) had its underperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 180 price target on the stock.
Receive News & Ratings for Adicet Bio Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adicet Bio Inc and related companies with MarketBeat.com's FREE daily email newsletter.
